Delivery Order SPE2DB20D3303-SPE2DB24FY9F3

Award Date 2/6/24
Potential Completion Date 2/7/24
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
The Defense Logistics Agency has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 500 tablets of Bupropion HCl XL 150 mg. The order, valued at $4,838.44, has a completion date of February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,863.34 firm fixed price delivery order contract for the supply of 4,564,029,023 units of Bupropion HCL XL 150 mg tablets. The contract has a period of performance through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has an existing $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The $23,494.99 firm fixed-price delivery order is for the supply of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of April 19, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide 500 units of BUPROPION HCL XL 300 MG TABLET. The contract has a total potential value of $5,376.14 and a completion date of February 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,656.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 500 tablets of Bupropion HCL XL 300 mg. This delivery order is part of a larger indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,829,178 tablets of Bupropion HCl XR 150 mg. The order has a potential value of $44,449.27 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution services company. The contract is for the supply of 4563637481 - Bupropion HCL XL 300 mg Tablets in 90s packaging, with a potential value of $1,056.40 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp has received numerous similar federal contract awards...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FY9F3
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit pharmaceutical distribution company. The $12,919.84 contract is for the delivery of the pharmaceutical product Bupropion HCL XL 150 mg tablets, with a completion date of February 7, 2024. This award is under a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 5/7/24, 11:48 AM